Published on FiercePharma (http://www.fiercepharma.com)

SPOTLIGHT: Merck KGaA leads team to sell Erbitux in Japan

By admin
Created Oct 17 2007 - 5:59am

Merck KGaA leads team to sell Erbitux in Japan
Call it a trifecta: ImClone Systems, Bristol-Myers Squibb and Merck KGaA are joining together to develop and market ImClone's cancer drug Erbitux in Japan, with Merck getting half the proceeds. Report [1]

Source URL: http://www.fiercepharma.com/story/spotlight-merck-kgaa-leads-team-sell-erbitux-japan/2007-10-17

Links:
[1] http://www.businessweek.com/ap/financialnews/D8SAUAS00.htm